Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- And Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions

Circulation - United States
doi 10.1161/circulationaha.109.849877
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent in Patients With Diabetes Mellitus * Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Final Results of a Self-Apposing Paclitaxel-Eluting Stent fOr the PErcutaNeous Treatment of De Novo Lesions in Native Bifurcated Coronary Arteries Study

EuroIntervention
MedicineCardiovascular MedicineCardiology
2016English

Controlled Release of Paclitaxel From Biodegradable Polymer Films for Drug-Eluting Stents

Polymer (Korea)
PolymersMaterials ChemistryPlasticsChemical Engineering
2010English

Two-Year Clinical Outcomes With Drug-Eluting Stents for Diabetic Patients With De Novo Coronary Lesions: Results From a Real-World Multicenter Registry

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Randomised Comparison of a Biodegradable Polymer Ultra-Thin Sirolimus-Eluting Stent Versus a Durable Polymer Everolimus-Eluting Stent in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Trial

EuroIntervention
MedicineCardiovascular MedicineCardiology
2018English

Propensity-Matched Lesion-Based Comparison of Midterm Outcomes of TAXUS Express and TAXUS Liberté Stents for De Novo Native Coronary Stenosis

Journal of Cardiology
Cardiovascular MedicineCardiology
2013English

Long-Term Clinical Outcomes of Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients With Coronary Artery Disease (LEADERS): 4 Year Follow-Up of a Randomised Non-Inferiority Trial

The Lancet
Medicine
2011English

Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2016English

Clinical Outcomes of Bioabsorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Two-Year Follow-Up of the DESSOLVE III Trial

EuroIntervention
MedicineCardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy